The Lexington Group Recommends Mirco-cap Gem, Elephant Talk Communications Corp


Posted October 14, 2013 by thelexingtongroup

Dutch-based Elephant Talk Communications is a leader in mobile security solutions, their breakthrough fraud prevention products when launched will earn massive revenues.

 
CHIYODA-KU, Japan -- The Lexington Group is cautious when recommending mirco-cap stocks, due to low liquidity and market capitalization, but Elephant Talk Communications Corp and its primary subsidiary Vaildsoft are fated for tremendous financial gains. They are a small corporation, with a market capitalization of about $100 million, who are trying to tackle a global problem worth an estimated $100 billion.

Dutch-based Elephant Talk Communications Corp and Vaildsoft provide a number of services to mobile networks. Vaildsoft is a security service, aimed at international fraud prevention. The concept is incredibly simple yet ingenious; it correlates the location of a user’s mobile phone with the point of origin of a transaction. If they are different it flags the transaction and prevents fraud in real time. If a card-holder and their mobile phone are in London, and their card is used in Zimbabwe it will prevent the transaction from taking place. Privacy is not an issue as Validsoft is anonymous; they are the only software security company in the world to receive three European Privacy Seals from EuroPriSe.

Small Cap Analyst, Matthew Stevens at The Lexington Group stated, “I have an enormous amount of confidence in Elephant Talk and Vaildsoft, as does their CEO who just invested a further $4.5 million of his own funds into the company. I fully expect this stock to climb at the minimum 150% in value over the next twelve months; we are recommending that our own clients invest immediately before Elephant Talk can secure more contracts with mobile phone operators and financial institutions.”

Over the past two years Elephant Talk has enjoyed financial success; their high revenue model based on transactions and recurring subscriptions has caused revenue to nearly double. In 2011, $5.8 million was earned to 2012 when $11.7 million was earned. They have also posted seven quarters of consecutive growth in monthly recurring revenue. In the period from July 12th to July 18th their stock has climbed nearly 25%.
-- END ---
Share Facebook Twitter
Print Friendly and PDF DisclaimerReport Abuse
Contact Email [email protected]
Issued By Lexington Group
Website The Lexington Group
Country Japan
Categories Business
Tags contact 81345209601 , matthew stevens , small cap analyst , the lexington group , thelexingtongroupcom
Last Updated October 14, 2013